Latest wearable sensor in Japan helps predict muscle fatigue:  It monitors sweat lactate during exercise, which indicates exercise intensity

Wearable monitors lactate for muscle fatigue prediction: A wearable sweat sensor that has a bigger sweat reservoir and continuously monitors lactate to help predict muscle fatigue has been designed by Tokyo University of Science researchers. A study found the wearable sustained a stable response for two hours, and sweat flow rate did not impact its measurement of lactate.

Hearing Aids May Cut Dementia Risk in Those at High Risk

Lower dementia risk seen with hearing-aid use in high-risk individuals: A study found that the use of hearing aids among older adults at higher risk of developing dementia was associated with 48% less cognitive change over three years.

Deep Learning Algorithm Predicts Need for Crohn’s Disease Therapy

Deep learning may guide Crohn’s Disease (CD) treatment: A deep learning model that analyzes capsule endoscopy videos identified patients newly diagnosed with Crohn’s disease who might benefit from biologic therapy, according to a study published in Therapeutic Advances in Gastroenterology. The model detected and accurately graded inflammation indicators in CE images and outperformed a standard scoring system when predicting the need for biologic therapy.

Researchers develop implantable heart valve that grows with a child

Implantable heart valve grows with a child thanks to new manufacturing method: A research team at the Wyss Institute and Harvard’s John A. Paulson School of Engineering and Applied Sciences has developed a nanofiber fabrication technique to rapidly manufacture heart valves with regenerative and growth potential. This new manufacturing method will likely be useful for other medical devices, they said.

MCED (methylation-based multicancer early detection) Test Can Aid Cancer Diagnosis in Symptomatic Patients

Test could diagnose cancer in patients with non-specific symptoms: A study in the journal The Lancet Oncology found that a methylation-based multicancer early detection test demonstrated a 98.4% specificity and 66.3% sensitivity, with its sensitivity increasing with the increase of cancer stage and age. “MCED test results can help assess the risk that a symptom is due to cancer, providing a means for primary care physicians to decide whom to urgently investigate,” researchers wrote.